Purchase Order 36C25226P0053

Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 12 on October 27, 2025, for the rental of cancer treatment devices to support immediate medical needs for veteran patients. The contract, valued at $49,748.73, calls for a three-month rental period with an ultimate completion date of January 27, 2026, and will be performed at the VA facility in Portsmouth, New Hampshire. This award does not utilize a set-aside designation and is issued under Novocure's existing Federal Supply Schedule contract with the Veterans Health Administration Medical Equipment and Supplies category (FSS-65-II-A), a multiple-award vehicle valued at $28.85 million and running through October 2027.

Novocure's Optune system, an FDA-approved non-invasive medical device for treating solid tumors including glioblastoma and mesothelioma, represents an advanced therapeutic option for the VA's cancer patient population. The company has consistently served as the prime contractor for VA medical centers nationwide, delivering proprietary medical devices and support services directly without subcontractors. This purchase order is one of numerous delivery orders issued through VISN 12 and other integrated service networks, enabling the Department of Veterans Affairs to expand veteran access to innovative cancer treatment technologies as part of its broader mission to provide cutting-edge medical care to the veteran population.